β-Thalassemia Intermedia: A Bird’s-Eye View
暂无分享,去创建一个
[1] D. Weatherall,et al. The α-thalassemias. , 2014, The New England journal of medicine.
[2] M. Cappellini,et al. Prevalence and Risk Factors for Pulmonary Arterial Hypertension in a Large Group of &bgr;-Thalassemia Patients Using Right Heart Catheterization: A Webthal Study , 2014, Circulation.
[3] Paul Tyan,et al. β-Thalassemia Intermedia: A Bird's-Eye View β-Talasemi İntermedya: Kuşbakişi , 2014 .
[4] M. Cappellini,et al. Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study , 2013, Annals of Hematology.
[5] M. Cappellini,et al. An update on thalassemia intermedia. , 2013, Lebanese Medical Journal.
[6] M. Cappellini,et al. Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia: a closer look at the role of siderosis. , 2013, Annals of hepatology.
[7] A. Taher,et al. Prevalence of Depression and Anxiety in Adult Patients with β-Thalassemia Major and Intermedia , 2012, International journal of psychiatry in medicine.
[8] A. Taher,et al. Cerebral infarction in β-thalassemia intermedia: breaking the silence. , 2012, Thrombosis research.
[9] M. Cappellini,et al. Longitudinal changes in serum ferritin levels correlate with measures of hepatic stiffness in transfusion-independent patients with β-thalassemia intermedia. , 2012, Blood cells, molecules & diseases.
[10] P. Ricchi,et al. Splenectomy is a risk factor for developing hyperuricemia and nephrolithiasis in patients with thalassemia intermedia: a retrospective study. , 2012, Blood cells, molecules & diseases.
[11] A. Taher,et al. β-thalassemia intermedia: a clinical perspective. , 2012, Cold Spring Harbor perspectives in medicine.
[12] Vip Viprakasit,et al. A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload. , 2012, Blood.
[13] C. Cesaretti,et al. Levels of growth differentiation factor-15 are high and correlate with clinical severity in transfusion-independent patients with β thalassemia intermedia. , 2011, Blood cells, molecules & diseases.
[14] M. Cappellini,et al. Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia , 2011, Haematologica.
[15] D. Weatherall. Thalassaemia: the long road from the bedside through the laboratory to the community , 2011, Transfusion medicine.
[16] Suzanne Koussa,et al. Health‐related quality of life in adults with transfusion‐independent thalassaemia intermedia compared to regularly transfused thalassaemia major: new insights , 2011, European journal of haematology.
[17] A. Koren,et al. Healing of refractory leg ulcer in a patient with thalassemia intermedia and hypercoagulability after 14 years of unresponsive therapy. , 2011, The Israel Medical Association journal : IMAJ.
[18] E. Neufeld,et al. Renal dysfunction in patients with thalassaemia , 2011, British journal of haematology.
[19] E. Neufeld,et al. A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload , 2011, Haematologica.
[20] J. Jankovic,et al. Iron chelation and neuroprotection in neurodegenerative diseases , 2011, Journal of Neural Transmission.
[21] C. Ponticelli,et al. Renal complications in transfusion-dependent beta thalassaemia. , 2010, Blood reviews.
[22] A T Taher,et al. Splenectomy and thrombosis: the case of thalassemia intermedia , 2010, Journal of thrombosis and haemostasis : JTH.
[23] D. Weatherall. Thalassemia: the long road from the bedside through the laboratory to the community , 2010, Nature Medicine.
[24] C. Hershko. Pathogenesis and management of iron toxicity in thalassemia , 2010, Annals of the New York Academy of Sciences.
[25] Nicolò Zanforlin,et al. The natural history of thalassemia intermedia , 2010, Annals of the New York Academy of Sciences.
[26] Raffaella Origa,et al. BETA THALASSEMIA , 2018, The Professional Medical Journal.
[27] M. Cappellini,et al. Age‐related complications in treatment‐naïve patients with thalassaemia intermedia , 2010, British journal of haematology.
[28] M. Cappellini,et al. Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion‐independent thalassemia intermedia compared to regularly transfused thalassemia major patients , 2010, American journal of hematology.
[29] M. Cappellini,et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. , 2010, Blood.
[30] A. Taher,et al. Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia , 2010, European Spine Journal.
[31] A. Beydoun,et al. Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia , 2010, Journal of thrombosis and haemostasis : JTH.
[32] M. Cappellini,et al. Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies , 2009, British journal of haematology.
[33] G. Buchanan,et al. Vascular complications after splenectomy for hematologic disorders. , 2009, Blood.
[34] P. Criado,et al. Prevalence of thrombophilia associated with leg ulcers , 2009, The British journal of dermatology.
[35] M. Gladwin,et al. Pulmonary complications of sickle cell disease. , 2008, The New England journal of medicine.
[36] M. Cappellini,et al. Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia , 2008, Haematologica.
[37] M. Cappellini,et al. Thalassemia and hypercoagulability. , 2008, Blood reviews.
[38] M. Khamaisi,et al. Renal Parenchymal Hypoxia, Hypoxia Response and the Progression of Chronic Kidney Disease , 2008, American Journal of Nephrology.
[39] R. Galanello,et al. No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia , 2008, Haematologica.
[40] J. Freyssinet,et al. Elevated levels of circulating procoagulant microparticles in patients with β-thalassemia intermedia , 2008, Haematologica.
[41] M. Cappellini,et al. Guidelines for the Clinical Management of Thalassaemia , 2008 .
[42] C. Borgna-Pignatti. Modern treatment of thalassaemia intermedia , 2007, British journal of haematology.
[43] T. Ganz,et al. Liver iron concentrations and urinary hepcidin in beta-thalassemia. , 2007, Haematologica.
[44] T. Ganz,et al. Liver iron concentrations and urinary hepcidin in β-thalassemia , 2007 .
[45] A. Phrommintikul,et al. Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia , 2006, Heart.
[46] M. Cappellini,et al. Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran , 2006, Thrombosis and Haemostasis.
[47] M. Cappellini,et al. Thalassemia intermedia: revisited. , 2006, Blood cells, molecules & diseases.
[48] M. Tsironi,et al. Extramedullary Hematopoiesis-Related Pleural Effusion: The Case of β-Thalassemia , 2006 .
[49] S. Perrotta,et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. , 2006, Blood.
[50] M. Nangaku. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. , 2005, Journal of the American Society of Nephrology : JASN.
[51] M. Cappellini,et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with -thalassemia , 2006 .
[52] E. Vichinsky,et al. Quality of Life in Patients with Thalassemia Intermedia Compared to Thalassemia Major , 2005, Annals of the New York Academy of Sciences.
[53] T. Coates,et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. , 2005, Blood.
[54] M. Karimi,et al. Hematologic and Clinical Responses of Thalassemia Intermedia Patients to Hydroxyurea During 6 Years of Therapy in Iran , 2005, Journal of pediatric hematology/oncology.
[55] M. Kabra,et al. Hydroxyurea in thalassemia intermedia—a promising therapy , 2005, Annals of Hematology.
[56] M. Cappellini. Overcoming the challenge of patient compliance with iron chelation therapy. , 2005, Seminars in hematology.
[57] M. Kabra,et al. Do alpha deletions influence hydroxyurea response in thalassemia intermedia? , 2005, Hematology.
[58] T. S. St. Pierre,et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. , 2005, Blood.
[59] D. Weatherall. History of genetic disease: Thalassaemia: the long road from bedside to genome , 2004, Nature Reviews Genetics.
[60] Asha Shah,et al. Thalassemia syndromes. , 2004, Indian journal of medical sciences.
[61] Tetsuhiro Tanaka,et al. Hypoxia-induced apoptosis in cultured glomerular endothelial cells: involvement of mitochondrial pathways. , 2003, Kidney international.
[62] S. Chuncharunee,et al. Pulmonary Arterial Hypertension in Previously Splenectomized Patients with β-Thalassemic Disorders , 2003 .
[63] A. Hoffbrand,et al. Clinical trial of deferiprone iron chelation therapy in β‐thalassaemia/haemoglobin E patients in Thailand , 2003, British journal of haematology.
[64] M. Gladwin,et al. Nitric oxide's reactions with hemoglobin: a view through the SNO-storm , 2003, Nature Medicine.
[65] P. Malasit,et al. Renal tubular dysfunction in α-thalassemia , 2003, Pediatric Nephrology.
[66] P. Malasit,et al. Renal tubular dysfunction in alpha-thalassemia. , 2003, Pediatric nephrology (Berlin, West).
[67] M. Treadwell,et al. Improving adherence with deferoxamine regimens for patients receiving chronic transfusion therapy. , 2001, Seminars in hematology.
[68] J. Norman,et al. Hypoxia promotes fibrogenesis in human renal fibroblasts. , 2000, Kidney international.
[69] M. Cappellini,et al. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. , 2000, British journal of haematology.
[70] F. Strutz,et al. Role of fibroblast activation in inducing interstitial fibrosis. , 2000, Journal of nephrology.
[71] E. Giarratano,et al. MR imaging of the brain: findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease. , 1999, AJR. American journal of roentgenology.
[72] J. Norman,et al. Hypoxia-Induced Changes in Extracellular Matrix Metabolism in Renal Cells , 1999, Nephron Experimental Nephrology.
[73] C. Koch,et al. Hypoxia induces renal tubular epithelial cell apoptosis in chronic renal disease. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[74] A. Cao,et al. Relationship between Genotype and Phenotype: Thalassemia Intermedia a , 1998, Annals of the New York Academy of Sciences.
[75] C. Chuang,et al. Adrenal extramedullary hematopoietic tumor in a patient with beta-thalassemia. , 1998, Journal of the Formosan Medical Association = Taiwan yi zhi.
[76] B. Brenner,et al. The hyperfiltration theory: a paradigm shift in nephrology. , 1996, Kidney international.
[77] Olivieri Nf. Reactivation of fetal hemoglobin in patients with beta-thalassemia. , 1996 .
[78] S. Aggarwal,et al. Case of the Season , 1995 .
[79] K. Parsa,et al. Nonsurgical approach to paraparesis due to extramedullary hematopoiesis. Report of two cases. , 1995, Journal of neurosurgery.
[80] M. Brezis,et al. Hypoxia of the renal medulla--its implications for disease. , 1995, The New England journal of medicine.
[81] M. Cappellini,et al. Genetic interactions in thalassemia intermedia: analysis of beta-mutations, alpha-genotype, gamma-promoters, and beta-LCR hypersensitive sites 2 and 4 in Italian patients. , 1995, American journal of hematology.
[82] L. N. de Tilly,et al. Case of the season. Thalassemia major with extramedullary hematopoiesis in the liver. , 1995, Seminars in roentgenology.
[83] M. Cappellini,et al. Thalassemia intermedia. , 1995, Haematologica.
[84] S. Hmida,et al. Red cell alloantibodies in patients with haemoglobinopathies. , 1994, Nouvelle revue francaise d'hematologie.
[85] G. Barosi,et al. Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin beta-thalassemia intermedia patients. , 1994, Blood.
[86] R. Lifeso,et al. Combined radiotherapeutic and surgical management of a spinal cord compression by extramedullary hematopoiesis in a patient with hemoglobin E beta-thalassemia. , 1994, Acta haematologica.
[87] F. Cossu,et al. Recurrence of spinal cord compression from extramedullary hematopoiesis in thalassemia intermedia treated with low doses of radiotherapy , 1993, American journal of hematology.
[88] E. Richter. [Extramedullary hematopoiesis with intraspinal extension in thalassemia]. , 1993, Aktuelle Radiologie.
[89] G. Papa,et al. Incidence and clinical study of ectopic erythropoiesis in adult patients with thalassemia intermedia. , 1992, Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna.
[90] A. Sumiyoshi,et al. Pulmonary microthromboemboli in thalassemic cases. , 1992, The Southeast Asian journal of tropical medicine and public health.
[91] A. Hohimer,et al. Hemodynamics and organ blood flow in fetal sheep subjected to chronic anemia. , 1991, The American journal of physiology.
[92] B. Brenner,et al. Anemia: a potent modulator of renal hemodynamics in models of progressive renal disease. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[93] J. Peristeri,et al. Red Cell Alloantibodies in Patients with Thalassemia , 1990, Vox sanguinis.
[94] B. Halliwell,et al. Role of free radicals and catalytic metal ions in human disease: an overview. , 1990, Methods in enzymology.
[95] D. Loukopoulos,et al. Prevention of thalassemia. , 1983, Schweizerische medizinische Wochenschrift.
[96] M. Pippard,et al. Ferrioxamine excretion in iron-loaded man. , 1982, Blood.
[97] E. Rachmilewitz,et al. Juvenile leg ulceration in beta-thalassemia major and intermedia. , 1982, Plastic and reconstructive surgery.
[98] S. Fucharoen,et al. Pulmonary artery obstruction in thalassaemia. , 1980, The Southeast Asian journal of tropical medicine and public health.
[99] F. Mastrangelo,et al. Function of the kidney in adult patients with Cooley's disease. A preliminary report. , 1975, Nephron.
[100] P. Ross,et al. Roentgen findings in extramedullary hematopoiesis. , 1969, The American journal of roentgenology, radium therapy, and nuclear medicine.
[101] J. Clegg,et al. Globin Synthesis in Thalassaemia: An in vitro Study , 1965, Nature.
[102] A. Stretton,et al. Genetic basis of the thalassaemia diseases. , 1959, Nature.
[103] H. Itano,et al. Genetic and Biochemical Studies of‘Intermediate’Types of Cooley's Anaemia * , 1955, British journal of haematology.
[104] G. Whipple,et al. Mediterranean disease-thalassemia(Erythroblastic anemia of cooley) , 1936 .
[105] W. S. Thayer,et al. Extramedullary Hematopoiesis in Anemias , 1928 .